Here, we present two protocols to study Phagocyte-Mycobacterium abscessus interactions: the screening of a transposon mutant library for bacterial intracellular deficiency and the determination of bacterial intracellular transcriptome from RNA sequencing. Both approaches provide insight into the genomic advantages and transcriptomic adaptations enhancing intracellular bacteria fitness.
What differentiates Mycobacterium abscessus from other saprophytic mycobacteria is the ability to resist phagocytosis by human macrophages and the ability to multiply inside such cells. These virulence traits render M. abscessus pathogenic, especially in vulnerable hosts with underlying structural lung disease, such as cystic fibrosis, bronchiectasis or tuberculosis. How patients become infected with M. abscessus remains unclear. Unlike many mycobacteria, M. abscessus is not found in the environment but might reside inside amoebae, environmental phagocytes that represent a potential reservoir for M. abscessus. Indeed, M. abscessus is resistant to amoebal phagocytosis and the intra-amoeba life seems to increase M. abscessus virulence in an experimental model of infection. However, little is known about M. abscessus virulence in itself. To decipher the genes conferring an advantage to M. abscessus intracellular life, a screening of a M. abscessus transposon mutant library was developed. In parallel, a method of RNA extraction from intracellular Mycobacteria after co-culture with amoebae was developed. This method was validated and allowed the sequencing of whole M. abscessus transcriptomes inside the cells; providing, for the first time, a global view on M. abscessus adaptation to intracellular life. Both approaches give us an insight into M. abscessus virulence factors that enable M. abscessus to colonize the airways in humans.
The genus Mycobacterium includes species ranging from harmless saprophytic organisms to major human pathogens. Well-known pathogenic species such as Mycobacterium tuberculosis, Mycobacterium marinum and Mycobacterium ulcerans belong to the subgroup of slow-growing mycobacteria (SGM). In contrast, the subgroup of rapid-growing mycobacteria (RGM) is characterized by their ability to form visible colonies in less than 7 days on agar medium. The RGM group comprises more than 180 species, mainly non-pathogenic saprophytic mycobacteria. Studies on RGM interactions with their hosts have mainly focused on Mycobacterium smegmatis and demonstrate that these mycobacteria are rapidly eliminated by the bactericidal action of macrophages.
Mycobacterium abscessus is one of the rare RGM that are pathogenic to humans and is responsible for a wide range of infections ranging from the skin and soft tissue infections to the pulmonary and disseminated infections. M. abscessus is considered, along with Mycobacterium avium, to be the main mycobacterial pathogen in cystic fibrosis patients1.
Various studies performed on M. abscessus indicate that this mycobacterium behaves like an intracellular pathogen, capable of surviving the bactericidal response of macrophages and fibroblasts in the lungs and skin, which is not usually observed in RGM2,3,4. M. abscessus genome analysis has identified metabolic pathways typically found in environmental microorganisms in contact with the soil, plants and aquatic environments, where free amoebae are often present5. They have also demonstrated that M. abscessus is endowed with several virulence genes not found in the saprophytic and non-pathogenic RGM, probably acquired by the horizontal gene transfer in a niche favorable to genetic exchange that might gather various amoeba resistant bacteria.
Experimentally, one of the first striking results was the observation of intracellular growth of M. abscessus in macrophages as well as for M. tuberculosis6. M. abscessus also resists the acidification of the phagosome, apoptosis and autophagy, three essential mechanisms of the cellular resistance to the infection2. It has even been shown that M. abscessus is able to establish an immediate communication between the phagosome and the cytosol, a more nutrient-rich environment that might favor bacterial multiplication2. Very little is known about the genomic advantages that M. abscessus possesses or has acquired to allow survival in an intracellular environment. Amoeba coculture is an efficient method that allowed the isolation of many new amoeba resistant bacteria as Mycobacterium massiliense7,8. An ability to multiply within amoebae was observed, in a model of aerosolization of M. abscessus in mice, which can confer an increased virulence to M. abscessus4. One hypothesis is that M. abscessus had developed genetic traits encountered within this environment to survive in phagocytic cells, which are different from other non-pathogenic RGM. These acquisitions might favor the ability to spread and its virulence in the human host.
This report describes tools and methods to highlight the genomic advantages conferred to M. abscessus to survive in the amoebae environment. For this purpose, the screening of M. abscessus transposon mutants is first described, on the Acanthamoeba castellanii type strain, which allows the identification of mutant's defective for intracellular growth. A second screening in macrophages is also reported, to confirm if this defect persists in the human host. Secondly, to understand which mechanisms are harnessed in M. abscessus to adapt to life in phagocytic cells and increase its virulence in the animal host, a method specifically adapted for M. abscessus was developed, after co-culture in the presence of amoebae that allowed the extraction of total RNA from intra-amoebal bacteria. As a consequence, a comprehensive view of M. abscessus genes that are required for an intracellular life was developed.
1. Library Screening
2. RNA Extraction of Intracellular Mycobacteria for Rnaseq Analysis
NOTE: This takes 4 months for experiments and 4 months for RNAseq analysis.
M. abscessus has the ability to resist and escape the bactericidal responses of macrophages and environmental protozoa such as amoebae. M. abscessus expresses virulence factors when grown in contact with amoebae, which makes it more virulent in mice4. The first objective of these methods was to identify the genes present in M. abscessus allowing its survival and multiplication within amoebae.
For this, a mutant library of M. abscessus subsp. massiliense, obtained by Tn delivery9, was screened following co-culture in the presence of amoebae, to identify mutants with attenuated growth in this intracellular environment (Figure 1). The behavior of the same mutants was also evaluated following co-culture with macrophages to analyze whether this growth attenuation was preserved in mice macrophages.
This blind transposon library screening approach, confirmed a defective replication phenotype for 47 of 6,000 mutants that had a survival of 50% or less in amoebae and/or macrophages, compared to controls10. To rule out mutants with attenuated intracellular survival that might be due to an intrinsic growth defect of the mycobacterium, the growth curves of all selected Tn mutants were evaluated in an in vitro liquid culture enriched medium (1% glucose-7H9). In vitro growth of all mutants was monitored by following OD600 of cultures every 2 days. The different mutants that displayed an in vitro growth defect compared to the corresponding wild-type strain were excluded from the study.
It was vitally important for this blind test to be reproduced each day using exactly the same protocol. The limitation of this technique was at the first visual screening, photographs were taken of each CFU to provide an accurate image for reference. In this group of mutants, 12 M. abscessus mutants (included duplicates) were identified in which the transposon was inserted into genes belonging to the ESX-4 locus of the type VII secretion system which underlines its importance in the intracellular growth of M. abscessus10.
Up until now, the analysis of M. abscessus virulence has essentially been based on the comparative analysis of the genome of M. abscessus with that of M. chelonae, a mycobacterium belonging to the same group but causing only infections of the skin in humans. The objective was to obtain a catalogue of the genes expressed during different co-culture conditions in order to better understand the adaptation and potentially virulence mechanisms involved during co-culture in the presence of environmental professional phagocytes. Analysis of this increased virulence through a comprehensive approach of total sequencing messenger RNAs of M. abscessus, was performed in order to detect the RNAs induced or repressed during amoeba co-cultures compared to the RNAs transcribed under in vitro conditions. The differential expression of these RNAs can confer to M. abscessus an enhanced "virulence" explaining the colonization of the upper airways in humans.
These co-cultures were again carried out in a minimum medium (no source of carbon or nitrogen) as described above, in order to prevent the extracellular growth of M. abscessus and to be representative of the environmental conditions faced by these mycobacteria and under the pressure of selection of an antibiotic throughout the duration of co-culture to select intracellular mycobacteria.
Therefore, a technique was developed to isolate the RNA from intracellular mycobacteria. The main difficulty with this extraction of mycobacterial RNA was avoiding contamination with amoebal RNA (Eukaryote type). To avoid this, lysis of amoeba was performed at different times post co-culture, using guanidinium thiocyanate (GTC); since intracellular mycobacteria are resistant. After this step, a mechanical extraction of the mycobacterial RNAs was carried out using a cell-homogenizer in the presence of zirconium beads. This technique allowed us to obtain mycobacterial RNA of good quality, with a RIN number of high quality, essential to improve the ability to undertake a complete analysis of the M. abscessus transcriptome, using the messenger RNA sequencing (mRNA) technique (Figure 2). This has never been done before and gave us a fundamental vision of the gene families induced or repressed, by grouping them according to their role: the response of M. abscessus to an environment limited in its source of nutrients and minerals, to a hypoxic or acidic environment and resistance of M. abscessus to oxidative and nitrosative stress and finally expression of the virulence of M. abscessus in environmental amoeba.
Figure 1: A. First visual screen of M. abscessus Tn mutants in amoeba. (A) large-scale screen of Tn mutants on amoebae is performed in 96-well plates with a random multiplicity of infection to quickly identify attenuated mutants. (B) Identification of the attenuated Tn mutants disrupted genes. Tn mutants' genomic DNA is fragmented with ClaI to clone the Tn insertion site. M. abscessus genomes harbors 2500 ClaI restriction sites which favors the obtaining of short DNA fragments but lowered the probability to clone the Tn insertion site (1/2500). The clones are selected with kanamycin, resistance bear by the transposon. The disrupted gene is identified by sequencing with a primer inside the Tn kanamycin resistance cassette (black arrow). Please click here to view a larger version of this figure.
Figure 2: Analysis of mycobacterial RNA extraction. (A) RNA extraction of intracellular M. abscessus during amoebae-M. abscessus co-culture. Amoebae co-cultures with M. abscessus are performed at a high multiplicity of infection (i.e., 100), in large volumes, with gentle agitation, to favor cell to bacteria contacts. After co-cultures, cells are harvested and lysed with a combination of GTC and ß-mercaptoethanol. The cell lysate-containing bacteria is treated with GTC again to weaken the bacteria cell wall to facilitate bacteria mechanic lysis prior to RNA extraction. (B) RNA quality and integrity assessment with a bioanalyzer. An electrophoresis gel is given on which rRNA is observed (23S, 16S and 5S). RIN must be above 8 to proceed with library preparation for sequencing and rRNA ratios (23S/16S) as high as possible depending on the organism, the ideal value being 2. Please click here to view a larger version of this figure.
The behavior of M. abscessus is much more similar to the behavior of pathogenic SGM such as M. tuberculosis than any other mycobacteria belonging to RGM2. The key element in the pathogenicity of SGM is their ability to survive or even multiply within antigen-presenting cells, such as macrophages and dendritic cells.
M. abscessus has acquired certain genomic advantages as shown by the total sequence of its genome14 in order to survive within a eukaryotic phagocytic cell. The genome of M. abscessus has been shown to be rapidly evolving and very plastic, with many recently introduced insertion sequences such as prophages and new genes15. Although there is less data on virulence factors in M. abscessus compared to M. tuberculosis, M. abscessus seems to be able to evolve rapidly and actively towards increased virulence. Until now, the analysis of M. abscessus virulence was essentially based on the comparative analysis of the genome of M. abscessus with that of M. chelonae, a mycobacterium belonging to the same group but causing infections limited to the skin in humans. Some genes not present in M. chelonae but present in M. abscessus, such as phospholipase C, have partially explained the resistance of M. abscessus after phagocytosis by environmental amoebae4.
The development of an amoeba co-culture technique supplemented with environmental samples has demonstrated unambiguously amoeba-mycobacterial interactions16,17. Thus, mycobacteria could be isolated from lysates co-cultured in the presence of amoebae in a water treatment plant18, and M. massiliense was isolated from the sputum of a patient after co-culture with amoebae, whereas the culture alone did not allow the isolation of this mycobacteria8. Amoebae are increasingly considered as an incubator for mycobacteria4 and Acanthamoebasp. as a natural environmental host for many non-tuberculous mycobacteria. Amoeba plus mycobacteria co-culture systems are increasingly being proposed as simple and rapid models to characterize factors involved in the intracellular growth of mycobacteria19,20,21,22,23,24.
In the environment, the interaction between mycobacteria and amoebae is poorly documented. The first article describing evidence of an association between mycobacteria and amoebae in the field came out in 2014, and this study focused on an analysis of a drinking water network25.
To our knowledge, this is the first screening described during a co-culture with amoebae. This study allowed us to demonstrate the role played by environmental phagocytes in the acquisition of virulence of an opportunistic pathogen affecting humans. In order to highlight those genes required for the intracellular survival of M. abscessus, a screen of a mutant library by transposition was carried out in a subspecies of the M. abscessus complex and in a clinical strain. This mutant library was screened with amoebae, this last having been demonstrated as a "training ground" for increasing the virulence of M. abscessus in mice4, similar to that observed with M. avium26. The major result was the discovery for the first time in mycobacteria of the essential role of the ESX-4 locus encoding a type VII secretion system, and ancestor of the ESX-1 locus considered essential for virulence and intracellular survival of M. tuberculosis Mycobacterium microti and M. marinum27,28,29,30,31.
The second objective was to obtain a catalogue of the genes expressed during different co-culture conditions in order to better understand the adaptation and potential virulence mechanisms involved during co-culture in the presence of environmental professional phagocytes. Analysis of this increased virulence through a comprehensive approach of total sequencing of messenger RNAs of M. abscessus, was performed in order to detect the RNAs induced or repressed during amoeba co-cultures compared to the RNAs transcribed under in vitro conditions. The differential expression of these RNAs can confer to M. abscessus an enhanced "virulence" explaining the colonization of the upper airways in humans. Among RGM species, M. abscessus is an exception to the non-pathogenic phenotype along with M. chelonae. The ability of M. abscessus to cause similar pathologies to tuberculous mycobacteria makes it even more unique. Many studies have reported the intracellular adaptations of M. tuberculosis to life inside macrophages32,33 but none have focused on M. abscessus adaptations in vivo. Transcriptional response of M. abscessus to hypoxia has been described34 though, highlighting the role of mycobactins and the dosR regulon as described in M. tuberculosis. Analysis of the M. abscessus transcriptome inside amoebae and macrophages gives an insight into the bacterial adaptions to intracellular life per se. A comparison of those transcriptomes permits the assessment of the role of amoebae in triggering M. abscessus virulence in humans and to the deciphering of specific adaptations to mammalian phagocytic cells. A supposition was made that the amoebal environment might constitute a 'training ground' for M. abscessus before transfer to human cells, in order to describe M. abscessus virulence in terms of evolutionary adaptations, renders this approach original.
We greatly acknowledge Pr. E.J. Rubin (Harvard Medical School, Boston, USA) for the precious gift of the mutant library, and Dr. Ben Marshall (Faculty of Medicine, University of Southampton, UK) for the corrections of the manuscript. We greatly acknowledge the French Patient Association for Cystic Fibrosis “Vaincre la Mucoviscidose” and “L’Association Gregory Lemarchal” for their financial support (RF20150501377). We also thank the National Agency for Research (ANR program DIMIVYR (ANR-13-BSV3-0007-01)), and the Région Ile-de-France (Domaine d’Intérêt Majeur Maladies Infectieuses et Emergentes) for funding the postdoctoral fellowship to V.L-M. L. L. is a doctoral fellow from the “Ministère de L’Enseignement Supérieur et de la Recherche”.
Name of Material/ Equipment | |||
24-well plates | Thermofisher | 11874235 | |
96-well plates | Thermofisher | 10687551 | |
Beadbeater | Bertin | Precellys 24 | |
Bioanalyzer | Agilent | ||
Genepulser Xcell | Biorad | ||
Nanodrop spectrophotometer 2000 | Thermofisher | ||
QuBit fluorometer | Thermofisher | Q33226 | |
zirconium beads/silica beads | Biospec products | 11079101Z | Beads |
Name of reagent/cells | |||
Acanthamoeba castellanii | ATCC | 30010 | strain |
Amikacin | Mylan | 150927-A | powder |
B-mercaptoethanol | Sigma-Aldrich | M6250 | solution |
CaCl2 | Sigma-Aldrich | C1016 | >93% granular anhydrous |
Chloroform | Fluka | 25666 | solution |
ClaI enzyme | New England Biolabs | R0197S | enzyme |
Columbia agar | Biomerieux | 43041 | 90 mm |
D-Glucose | Sigma-Aldrich | G8270 | powder |
DMEM | Thermofisher | 11500596 | medium |
DNase and RNase free water | Invitrogen | 10977-035 | solution |
E. coli electrocompetent | Thermofisher | 18265017 | bacteria |
EDTA | Sigma-Aldrich | E4884 | powder |
Escherichia coli | Clinical isolate | personal stock | bacteria |
Fe(NH4)2(SO4)-6H20 | EMS | 15505-40 | sulfate solution 4% aqueous |
Fetal Calf Serum | Gibco | 10270 | serum |
Glycerol | Sigma-Aldrich | G5516 | solution |
Guanidium thiocyanate | Euromedex | EU0046-D | powder |
Isopropanol | Sigma-Aldrich | I9516 | solution |
J774.2 macrophages | Sigma-Aldrich | J774.2 | Strain |
kanamycin | Sigma-Aldrich | 60615 | powder |
KH2PO4 | Sigma-Aldrich | P0662 | Monobasic, anhydrous |
LB liquid medium | Invitrogen | 12795-027 | powder |
Lysozyme | Roche | 10837059001 | powder |
MgSO4 | Labosi | M275 | pur |
Microbank TM (cryotubes with beads) | Pro-Lab Diagnostic | PL.170/M | |
Middlebrook 7H11 medium | Sigma-Aldrich | M0428 | powder |
Middlebrook 7H9 medium | Thermofisher | 11753473 | powder |
Müller-Hinton agar | Biorad | 3563901 | powder |
N-Lauryl-sarcosine | Merck | S37700 416 | powder |
Na2HPO4-7H2O | Sigma-Aldrich | S9390 | 98-102% |
Phenol/chloroforme | Sigma-Aldrich | 77617 | solution |
Proteinase K | Thermofisher | EO0491 | powder |
proteose peptone | BD | 211684 | enzymatic digest of animal tissue |
pUC19 plasmid | New England Biolabs | 54357 | plasmid |
SDS 20% | Biorad | 1610418 | solution |
Sodium citrate | Calbiochem | 567446 | powder |
Thiourea | Sigma-Aldrich | 88810 | powder |
Tris | Sigma-Aldrich | 154563 | powder |
Trizol | Thermofisher | 12044977 | solution |
Tween 80 | Sigma-Aldrich | P1754 | solution |
Yeast extract | BD | 212750 | |
Kit | |||
AMBION DNase kit | Thermofisher | 10792877 | kit |
DNA Agilent Chip | Agilent | 5067-1504 | kit |
GeneJET Plasmid Miniprep kit | Thermofisher | K0503 | kit |
PureLink PCR Purification kit | Invitrogen | K310001 | kit |
Quant-It" assays kit | Thermofisher | Q33140/Q32884 | kit |
T4 DNA ligase | Invitrogen | Y90001 | kit |
TruSeq Stranded RNA LT prep kit | Illumina | 15032611 | kit |